CoChat

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

Open access
Picarda, Elodie, Ohaegbulam, Kim C., Zang, Xingxing · 2016 · Clinical Cancer Research

The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.

Abstract

B7-H3 (CD276) is an important immune checkpoint member of the B7 and CD28 families. Induced on antigen-presenting cells, B7-H3 plays an important role in the inhibition of T-cell function. Importantly, B7-H3 is highly overexpressed on a wide range of human solid cancers and often correlates with both negative prognosis and poor clinical outcome in patients. Challenges remain to identify the receptor(s) of B7-H3 and thus better elucidate the role of the B7-H3 pathway in immune responses and tumor evasion. With a preferential expression on tumor cells, B7-H3 is an attractive target for cancer immunotherapy. Based on the clinical success of inhibitory immune checkpoint blockade (CTLA-4, PD-1, and PD-L1), mAbs against B7-H3 appear to be a promising therapeutic strategy worthy of development. An unconventional mAb against B7-H3 with antibody-dependent cell-mediated cytotoxicity is currently being evaluated in a phase I clinical trial and has shown encouraging preliminary results. Additional therapeutic approaches in targeting B7-H3, such as blocking mAbs, bispecific mAbs, chimeric antigen receptor T cells, small-molecule inhibitors, and combination therapies, should be evaluated, as these technologies have already shown positive results in various cancer settings. A better understanding of the B7-H3 pathway in humans will surely help to further optimize associated cancer immunotherapies. Clin Cancer Res; 22(14); 3425–31. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-15-2428

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 71 references

Cited by

See all 586

Metadata

Authors
Picarda, E., Ohaegbulam, K. C., & Zang, X.
Affiliations
  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
  • Albert Einstein College of Medicine (US)
Corresponding author
Zang, Xingxing
Venue
Clinical Cancer Research
Published
2016-07-14
Volume
22
Issue
14
Pages
3425-3431
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2407062242
Cited by
582
References
72
Citations by year
2026: 59 · 2025: 52 · 2024: 74 · 2023: 65 · 2022: 100 · 2021: 77 · 2020: 61 · 2019: 47 · 2018: 27 · 2017: 18 · 2016: 2
FWCI
16.88
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R01CA175495)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100525)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
B7-H3, immune checkpoint, cancer immunotherapy, monoclonal antibodies, antibody-dependent cellular cytotoxicity, bispecific antibodies, chimeric antigen receptor T cells, small molecule inhibitors, tumor immune evasion, T cell suppression, solid tumors
MeSH terms
Antibodies, Monoclonal, Antibody-Dependent Cell Cytotoxicity, Antigen-Presenting Cells, Humans, Immunotherapy, Neoplasms, T-Lymphocytes, Signal Transduction, Clinical Trials, Phase I as Topic, B7 Antigens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-15-2428
The paper
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016). Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-15-2428

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.